Amit Sinha

Amit Sinha is a highly accomplished professional with extensive experience in investment banking and life sciences. Currently, Amit serves as Partner, CIO, and Global Head of Life Sciences Investing at Goldman Sachs, where responsibilities include leading a team dedicated to investing in emerging therapeutics companies. Amit's previous roles at Goldman Sachs encompass leadership positions in biotechnology investment banking and healthcare M&A. In addition to investment banking, Amit is actively involved in various governance roles, serving on the Board of Trustees for Stanford University and as a member of the Board of Directors for Stanford Health Care and Lucile Packard Children's Hospital. Additionally, Amit holds board positions at Ajax Therapeutics and MOMA Therapeutics, focusing on innovative biopharmaceutical developments. Amit's educational background includes an MBA from Harvard Business School and a Bachelor of Science in Biology with Honors from Stanford University.